Limited dissemination of pathogenic SIV after vaginal challenge of rhesus monkeys immunized with a live, attenuated lentivirus

Virology

Volumn 392, Issue 2, 2009, Pages 260-270

  Stone, Mars ^a,b   Ma, Zhong Min ^a,b   Genescà, Meritxell ^a,b   Fritts, Linda ^a   Blozois, Shelley ^a   McChesney, Michael B ^b   Miller, Christopher J ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Attenuated SHIV; Dissemination; HIV transmission; Sexual transmission

Indexed keywords

LIVE VACCINE; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; T CELL DEPLETION; TISSUE DISTRIBUTION; VIREMIA; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; LENTIVIRUS; MACACA MULATTA; RNA, VIRAL; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINES, ATTENUATED; VAGINA; VIREMIA;

AIDS VIRUS; ANIMALIA; LENTIVIRUS; MACACA; MACACA MULATTA; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 69849096830     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.06.052     Document Type: Article

References (27)

1. Abel K., Compton L., Rourke T., Montefiori D., Lu D., Rothaeusler K., Fritts L., Bost K., and Miller C.J. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses. J. Virol. 77 5 (2003) 3099-3118
2. Abel K., La Franco-Scheuch L., Rourke T., Ma Z.M., De Silva V., Fallert B., Beckett L., Reinhart T.A., and Miller C.J. Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency Virus 89.6-immunized rhesus macaques. J. Virol. 78 2 (2004) 841-854
3. Almond N., Kent K., Cranage M., Rud E., Clarke B., and Stott E.J. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345 8961 (1995) 1342-1344
4. Berry N., Stebbings R., Ferguson D., Ham C., Alden J., Brown S., Jenkins A., Lines J., Duffy L., Davis L., Elsley W., Page M., Hull R., Stott J., and Almond N. Resistance to superinfection by a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8). J. Gen. Virol. 89 9 (2008) 2240-2251
5. Busch M., Abel K., Li J., Piatak M., Lifson J.D., and Miller C.J. Efficacy of a SHIV 89.6 proviral DNA vaccine against mucosal SIVmac239 Challenge. Vaccine 23 (2005) 4036-4047
6. Genesca M., Li J., Fritts L., Chohan P., Bost K., Rourke T., Blozis S.A., McChesney M.B., and Miller C.J. Depo-Provera abrogates attenuated lentivirus-induced protection in male rhesus macaques challenged intravenously with pathogenic SIVmac239. J. Med. Primatol. 36 4-5 (2007) 266-275
7. Genescà M., Skinner P.J., Hong J.J., Li J., Bost K., Lu D., McChesney M.B., and Miller C.J. With minimal systemic T cell expansion, CD8+ T cells mediate protection from vaginal SIV challenge in rhesus macaques immunized with attenuated SHIV89.6. J. Virol. 82 (2008) 11181-11196
8. Genescà M., Skinner P.J., Bost K., Lu D., Wang Y., Rourke T.L., Haase A.T., McChesney M.B., and Miller C.J. Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys. Mucosal Immunol. 1 (2008) 219-228
9. Genesca M., McChesney M.B., and Miller C.J. Antiviral CD8+ T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6. J. Intern. Med. 265 1 (2009) 67-77
10. Gundlach B.R., Lewis M.G., Sopper S., Schnell T., Sodroski J., Stahl-Hennig C., and Uberla K. Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain. J. Virol. 74 8 (2000) 3537-3542
11. Hu J., Pope M., Brown C., O'Doherty U., and Miller C.J. Immunophenotypic characterization of SIV-infected dendritic cells in the cervix, vagina and draining lymph nodes of rhesus macaques. Lab. Invest. 78 (1998) 435-451
12. Hu J., Gardner M.B., and Miller C.J. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J. Virol. 74 (2000) 6087-6095
13. Khatissian E., Monceaux V., Cumont M.C., Kieny M.P., Aubertin A.M., and Hurtrel B. Persistence of pathogenic challenge virus in macaques protected by simian immunodeficiency virus SIVmacDeltanef. J. Virol. 75 (2001) 1507-1515
14. Kwofie T.B., Miura T., Ibuki K., Enose Y., Suzuki H., Ui M., Kuwata T., and Hayami M. Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection. Arch. Virol. 147 6 (2002) 1091-1104
15. Lohman B.L., McChesney M.B., Miller C.J., McGowan E., Joye S.M., Van Rompay K.K.A., Reay E., Antipa L., Pedersen N.C., and Marthas M.L. A partially attenuated simian immunodeficiency virus induces host immunity that correlates to resistance to pathogenic virus challenge. J. Virol. 68 (1994) 7021-7029
16. Mackay G.A., Liu Z., Singh D.K., Smith M.S., Mukherjee S., Sheffer D., Jia F., Adany I., Sun K.H., Dhillon S., Zhuge W., and Narayan O. Protection against late-onset AIDS in macaques prophylactically immunized with a live simian HIV vaccine was dependent on persistence of the vaccine virus. J. Immunol. 173 (2004) 4100-4107
17. Miller C.J., McChesney M.B., Lu X., Dailey P.J., Chutkowski C., Lu D., Brosio P., Roberts B., and Lu Y. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J. Virol. 71 3 (1997) 1911-1921
18. Okoye A., Park H., Rohankhedkar M., Coyne-Johnson L., Lum R., Walker J.M., Planer S.L., Legasse A.W., Sylwester A.W., Piatak Jr. M., Lifson J.D., Sodora D.L., Villinger F., Axthelm M.K., Schmitz J.E., and Picker L.J. Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis. J. Exp. Med. 206 7 (2009) 1575-1588
19. Reynolds M.R., Weiler A.M., Weisgrau K.L., Piaskowski S.M., Furlott J.R., Weinfurter J.T., Kaizu M., Soma T., Leon E.J., MacNair C., Leaman D.P., Zwick M.B., Gostick E., Musani S.K., Price D.A., Friedrich T.C., Rakasz E.G., Wilson N.A., McDermott A.B., Boyle R., Allison D.B., Burton D.R., Koff W.C., and Watkins D.I. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. J. Exp. Med. 205 11 (2008) 2537-2550
20. Rose J., Silvera P., Flanagan B., Kitchin P., and Almond N. The development of PCR based assays for the detection and differentiation of simian immunodeficiency virus in vivo. J. Virol. Methods 51 2-3 (1995) 229-239
21. Ruprecht R.M. Live attenuated AIDS viruses as vaccines: promise or peril?. Immunol. Rev. 170 (1999) 135-149
22. Shibata R., Siemon C., Czajak S.C., Desrosiers R.C., and Martin M.A. Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. J. Virol. 71 (1997) 8141-8148
23. Silverstein P.S., Mackay G.A., Mukherjee S., Li Z., Piatak Jr. M., Lifson J.D., Narayan O., and Kumar A. Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with time. J. Virol. 74 22 (2000) 10489-10497
24. Silverstein P.S., Mackay G.A., Mukherjee S., Li Z., Piatak Jr. M., Lifson J.D., Narayan O., and Kumar A. Pathogenic simian/human immunodeficiency virus SHIVKU inoculated into immunized macaques caused infection, but virus burdens progressively declined with time. J. Virol. 74 22 (2000) 10489-10497
25. Stebbings R., Stott J., Almond N., Hull R., Lines J., Silvera P., Sangster R., Corcoran T., Rose J., Cobbold S., Gotch F., McMichael A., and Walker B. Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. AIDS Res. Hum. Retrovir. 14 13 (1998) 1187-1198
26. Ui M., Kuwata T., Igarashi T., Ibuki K., Miyazaki Y., Kozyrev I.L., Enose Y., Shimada T., Uesaka H., Yamamoto H., Miura T., and Hayami M. Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs. Virology 265 (1999) 252-263
27. Wakrim L., Le Grand R., Vaslin B., Ch éret A., Matheux F., Theodoro F., Roques P., Nicol-Jourdain I., and Dormont D. Superinfection of HIV-2-preinfected macaques after rectal exposure to a primary isolate of SIVmac251. Virology 221 2 (1996) 260-270